EN

Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Campus life

Discover the campuses

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Join our programs

Shaker Gene.iO ATIGE

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Directories Our network

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Come to our events

Innovate with us

Discover >

Quick access

Company

EndoGene.Bio

Laboratoiry R&D : 5 rue Henri Desbruères
91000 Evry-Courcouronnes

Head office: 3 boulevard de Sébastopol
75001 Paris

Email : info@endogene.bio

CEO : Maria Teresa Perez Zaballos
Web Site >
EndoGene.Bio - Genopole's Company EndoGene.Bio - Genopole's Company

#Health #Diagnostics #Healthtech

  • Biotech
  • Femtech
  • Diagnostics
  • Endometriosis
  • Epigenetics

Field of Activity

Research & development for an in vitro diagnostic tool for endometriosis

Background
EndoGene.Bio is the result of two women uniting their competencies: Maria Teresa Perez Zaballos, doctor in medical devices and ex portfolio expansion manager at Merck, and Madeleine Moscatelli, doctor in epigenetics. Their shared objective is to improve the management of women’s diseases. As a first mission, they are developing a method to diagnose endometriosis rapidly and efficaciously.

Description of the Products / Services / Technology
Despite affecting one woman in ten, it can take up to seven years to correctly identify endometriosis because of a lack of reliable and specific diagnostics. EndoGene.Bio seeks to change that by developing a diagnostic tool based on epigenetic biomarkers in menstrual blood samples that patients can take themselves in the comfort of their own homes.

Customer references / Collaborations / Highlights
EndoGene.Bio obtained a pre-seed investment from the start-up accelerator Entrepreneur First and has partnered with two hospitals to validate its proof of concept.
A seed funding campaign is also underway.

Collaborations Sought
Research laboratories, hospitals, pharmaceutical companies and biotechs developing treatments in the setting of endometriosis.

  • More informations

    Strengths: Advisory board including a KOL in endometriosis and experts in business development and women’s health; international hospital; dynamic, complementary and multidisciplinary team.

    Innovation assets: Developing a novel, disruptive approach to the diagnosis of endometriosis.

     

Share
Genopole’s Companies

#Health

In same field

Orinova

Orinova

is developing a breakthrough innovation in oncology with a patented nanomedicine incorporating a unique dual therapy: a chemotherapy molecule combined with gold nanoparticles.

Discover
AGS Therapeutics - log

AGS Therapeutics

AGS Therapeutics is a biotech company pioneering the use of microalgae extracellular vesicles (MEVs) as a universal delivery system for innovative therapeutics, vaccines and gene therapies.

Discover
Logo biotech 5H45

5 H 45

A protein-based nanofilm technology offers the first non-toxic, semi-permanent hair treatment that allows users to safely change their hair style without damage.

Discover
BioHive - Genopole Company Shaker - Gene.iO

BioHive

BioHive provides advanced analysis for dermatological products using innovative skin organoids derived from human stem cells, for toxicity and efficacy evaluations.

Discover
Alt Biotech - Genopole's Company Gene.iO#3

Alt Biotech

Alt Biotech offers an innovative bioproduction platform for non-therapeutic recombinant proteins: productive, scalable, with low environmental impact

Discover
Vitropep -entreprise genopole

Vitropep

Vitropep developed a unique technology allowing to inject certain peptides without cold chain and with self-administration.

Discover
Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

Discover

bYoRNA

Platform for the bioproduction of RNA through fermentation in eukaryotic cells, a paradigm shift from in vitro synthesis

Discover
Kyron.Bio - Genopole's Company

Kyron.Bio

Kyron.Bio is a biotech company using synthetic biology to produce new therapies with high yield, activity, and stability standards.

Discover
CGenetix - Entreprise génopolitaine

CGenetix

CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

Discover
Exosome Analytics - Entreprise génopolitaine

Exosome Analytics

Exosome Analytics develops techniques for EVs isolation and highly sensitive detection of protein markers on EVs for their application in liquid biopsy.

Discover
Maison M - Startup génopolitaine

Maison M

Personalized and sustainable Cosmetic House inspired by various and unique beauties. The innovative Maison M lipstick delivers any shade customized by its user.

Discover
Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover
Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover
StemSelect - Entreprise génopolitaine

StemSelect

The aim of StemSelect is to pave the way for a general access to cell therapy. The company develops a rapid isolation method of stem cells derived from one’s own fat tissue.

Discover
Synsight - Genopole's Company

Synsight

Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).

Discover
Sebia - Genopole's Company

Sebia

Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.

Discover
IntegraGen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover
Généthon - Genopole's Laboratory

Généthon

Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.

Discover

Enterome

Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota.

Discover
View all >
With the support from
Région île de France
Ministère de l'Enseignement supérieur et de la recherche AFM-Téléthon
Communauté d'agglomération Grand Paris Sud
Département de l'Essonne - Terre D'avenirs Ville d'Evry-Courcouronnes 2023 CEA Inserm Centre hospitalier Sud Francilien Université d'Evry - Paris Saclay Université PAris-Saclay SEM Genopole

Keep up to date with Genopole’s latest events and news